may be partly that they rejected AZ jabs for several months and so they have fallen behind. So whereas the UK had a relatively miserable first wave, it's continental Europe that has a problem now.
Also, the CEO suggests the AZ shot may well encourage the development of long term immunity by training T-cells to activate.
The story was on UK news websites, then vaporised when I went to get the link. May be legal action of some sort.